SG11201909967QA - Formulations for extending lifespan and healthspan - Google Patents
Formulations for extending lifespan and healthspanInfo
- Publication number
- SG11201909967QA SG11201909967QA SG11201909967QA SG11201909967QA SG 11201909967Q A SG11201909967Q A SG 11201909967QA SG 11201909967Q A SG11201909967Q A SG 11201909967QA SG 11201909967Q A SG11201909967Q A SG 11201909967QA
- Authority
- SG
- Singapore
- Prior art keywords
- blvd
- redwood
- international
- novato
- rule
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 240000005020 Acaciella glauca Species 0.000 abstract 3
- 235000003499 redwood Nutrition 0.000 abstract 3
- 230000032683 aging Effects 0.000 abstract 2
- 208000036119 Frailty Diseases 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
- A23K20/126—Lactones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Fodder In General (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 November 2018 (01.11.2018) WIPO I PCT ~~ll~~~~~~~~ 011101010VIIIOH olo oi olo iimo oo1 mom ow (10) International Publication Number WO 2018/200736 A2 (51) International Patent Classification: A61K 31/4745 (2006.01) A61K 31/19 (2006.01) (21) International Application Number: PCT/US2018/029455 (22) International Filing Date: 25 April 2018 (25.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/489,884 25 April 2017 (25.04.2017) US 62/646,734 22 March 2018 (22.03.2018) US (71) Applicant: THE BUCK INSTITUTE FOR RESEARCH ON AGING [US/US]; 8001 Redwood Blvd., Novato, CA 94945 (US). (72) Inventors: KENNEDY, Brian; 8001 Redwood Blvd., No- vato, CA 94945 (US). LITHGOW, Gordon, J.; 8001 Redwood Blvd., Novato, CA 94945 (US). WELDON, Thomas; 8001 Redwood Blvd., Novato, CA 94945 (US). EDGAR, Daniel; 8001 Redwood Blvd., Novato, CA 94945 (US). LUCANIC, Mark; 8001 Redwood Blvd., Novato, CA 94945 (US). (74) Agent: MCNAMARA, Laurie, K.; Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto, CA 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). = (54) Title: FORMULATIONS FOR EXTENDING LIFESPAN AND HEALTHSPAN 8/ 2007 36 A2 Fig. 11A 1-1 (57) : Described herein are compositions for delaying onset or delaying progression of frailty, reversing aging phenotype, © extending healthspan, compressing morbidity, increasing lifespan and reducing formation of senescent cells. C [Continued on next page] WO 2018/200736 A2 MIDIOHOMMIEFIEHIMMEllilIMIONEEDIS Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(11)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: without international search report and to be republished upon receipt of that report (Rule 48.2(g))
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762489884P | 2017-04-25 | 2017-04-25 | |
US201862646734P | 2018-03-22 | 2018-03-22 | |
PCT/US2018/029455 WO2018200736A2 (en) | 2017-04-25 | 2018-04-25 | Formulations for extending lifespan and healthspan |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201909967QA true SG11201909967QA (en) | 2019-11-28 |
Family
ID=63920459
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202107237SA SG10202107237SA (en) | 2017-04-25 | 2018-04-25 | Formulations for extending lifespan and healthspan |
SG11201909967Q SG11201909967QA (en) | 2017-04-25 | 2018-04-25 | Formulations for extending lifespan and healthspan |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202107237SA SG10202107237SA (en) | 2017-04-25 | 2018-04-25 | Formulations for extending lifespan and healthspan |
Country Status (11)
Country | Link |
---|---|
US (2) | US20200188327A1 (en) |
EP (1) | EP3615029A4 (en) |
JP (2) | JP2020517689A (en) |
KR (2) | KR102643567B1 (en) |
CN (2) | CN110913847A (en) |
AU (2) | AU2018260646A1 (en) |
BR (1) | BR112019022455A2 (en) |
CA (1) | CA3061381A1 (en) |
IL (1) | IL308093A (en) |
SG (2) | SG10202107237SA (en) |
WO (1) | WO2018200736A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7499259B2 (en) | 2018-09-25 | 2024-06-13 | ポンス デ レオン ヘルス デジグネイテッド アクティビティ カンパニー | Process for producing calcium alpha-ketoglutarate |
WO2020086733A1 (en) * | 2018-10-24 | 2020-04-30 | Ponce De Leon Health Designated Activity Company | Nicotinamide riboside compositions for healthspan extension |
WO2020252014A1 (en) * | 2019-06-10 | 2020-12-17 | Ponce De Leon Health, Inc. | Sustained-release compositions of alpha-ketoglutarate |
CA3142781A1 (en) * | 2019-06-10 | 2020-12-17 | Buck Institute For Research On Aging | Methods and compositions for altering senescence associated secretory phenotype |
CN113018288A (en) * | 2019-12-25 | 2021-06-25 | 同济大学 | Use of alpha-ketoglutaric acid in the manufacture of a medicament |
WO2021155341A1 (en) * | 2020-02-01 | 2021-08-05 | Ageless Sciences, Inc. | Compositions and methods for treating aging-related disorders |
CA3188646A1 (en) * | 2020-07-02 | 2022-01-06 | Ponce De Leon Health Designated Activity Company | Compositions and methods for treating crp-mediated diseases |
CN113244182A (en) * | 2021-04-30 | 2021-08-13 | 雅本化学股份有限公司 | Alpha-ketoglutarate calcium vitamin C effervescent tablet and preparation method thereof |
WO2023212104A1 (en) * | 2022-04-27 | 2023-11-02 | The Regents Of The University Of California | Methods and agents for preventing skeletal aging, osteoporosis and obesity |
WO2024039646A1 (en) * | 2022-08-15 | 2024-02-22 | Mayo Foundation For Medical Education And Research | Methods and materials for using and assessing anti-senescence treatments within mammals |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451341B1 (en) * | 1990-02-05 | 2002-09-17 | Thomas J. Slaga | Time release formulation of vitamins, minerals and other beneficial supplements |
US20030190381A1 (en) * | 2001-02-02 | 2003-10-09 | Bland Jeffrey S. | Medical composition for balancing bodily processes |
WO2006066244A2 (en) * | 2004-12-17 | 2006-06-22 | Cash Alan B | Method for extending lifespan and delaying the onset of age-related disease |
US20070135376A1 (en) * | 2005-06-20 | 2007-06-14 | Accera, Inc. | Method to reduce oxidative damage and improve mitochondrial efficiency |
PL226695B1 (en) * | 2006-07-03 | 2017-08-31 | Danuta Kruszewska | Agent for preventing and/or inhibiting the colonization of Helicobater pylori and its application |
AU2008271307B2 (en) * | 2007-07-02 | 2013-10-24 | Protista Biotechnology Ab | New use of known pharmacologically active chemical compounds |
EP2033623A1 (en) * | 2007-09-07 | 2009-03-11 | Cutech S.R.L. | Compositions comprising ornithine ketoglutarate (OKG) |
DE102009016119A1 (en) * | 2009-04-03 | 2010-10-14 | Evonik Degussa Gmbh | Nutritional supplement containing alpha-keto acids to support diabetes therapy |
EP2965763B8 (en) * | 2009-04-10 | 2018-08-15 | Haiyan Qi | Anti-aging agents |
CN102740870B (en) * | 2009-06-12 | 2016-06-29 | 基因雷克斯制药有限公司 | Japan's Herba Diclipterae Chinensis organic extract purposes in preparation is used for treatment or prophylaxis of hypertension medicine |
FR2953139B1 (en) * | 2009-11-27 | 2012-04-13 | Servier Lab | PHARMACEUTICAL COMPOSITION COMPRISING STRONTIUM SALT, VITAMIN D AND CYCLODEXTRIN |
RU2013151085A (en) * | 2011-04-18 | 2015-05-27 | Нестек С.А. | NUTRITIONAL COMPOSITIONS CONTAINING α-HYDROXYSIOCAPRIC ACID (α-HICA), AND METHODS OF USE |
CN106163513A (en) * | 2014-02-12 | 2016-11-23 | 加利福尼亚大学董事会 | For treating compositions and the method for old and feeble and age-related disease and symptom |
EP3160460B1 (en) * | 2014-06-30 | 2020-08-05 | The Regents of the University of California | Ketobutyrate compounds and compositions for treating age-related symptoms and diseases |
AU2015296098B2 (en) * | 2014-07-29 | 2019-06-27 | Shenzhen Hightide Biopharmaceutical, Ltd. | Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof |
-
2018
- 2018-04-25 EP EP18790088.1A patent/EP3615029A4/en active Pending
- 2018-04-25 AU AU2018260646A patent/AU2018260646A1/en not_active Abandoned
- 2018-04-25 CA CA3061381A patent/CA3061381A1/en active Pending
- 2018-04-25 CN CN201880040786.6A patent/CN110913847A/en active Pending
- 2018-04-25 JP JP2019557844A patent/JP2020517689A/en active Pending
- 2018-04-25 CN CN202310254296.9A patent/CN116492326A/en active Pending
- 2018-04-25 WO PCT/US2018/029455 patent/WO2018200736A2/en unknown
- 2018-04-25 SG SG10202107237SA patent/SG10202107237SA/en unknown
- 2018-04-25 IL IL308093A patent/IL308093A/en unknown
- 2018-04-25 BR BR112019022455-6A patent/BR112019022455A2/en unknown
- 2018-04-25 KR KR1020197034443A patent/KR102643567B1/en active IP Right Grant
- 2018-04-25 SG SG11201909967Q patent/SG11201909967QA/en unknown
- 2018-04-25 US US16/607,855 patent/US20200188327A1/en not_active Abandoned
- 2018-04-25 KR KR1020237041323A patent/KR20230167450A/en not_active Application Discontinuation
-
2022
- 2022-11-30 JP JP2022192458A patent/JP2023027149A/en active Pending
- 2022-12-14 US US18/066,181 patent/US20230127906A1/en active Pending
-
2024
- 2024-05-30 AU AU2024203624A patent/AU2024203624A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200188327A1 (en) | 2020-06-18 |
KR102643567B1 (en) | 2024-03-05 |
CN116492326A (en) | 2023-07-28 |
WO2018200736A2 (en) | 2018-11-01 |
SG10202107237SA (en) | 2021-08-30 |
WO2018200736A3 (en) | 2019-11-28 |
AU2024203624A1 (en) | 2024-06-20 |
CN110913847A (en) | 2020-03-24 |
JP2023027149A (en) | 2023-03-01 |
IL308093A (en) | 2023-12-01 |
US20230127906A1 (en) | 2023-04-27 |
EP3615029A4 (en) | 2021-04-21 |
BR112019022455A2 (en) | 2020-05-12 |
JP2020517689A (en) | 2020-06-18 |
AU2018260646A1 (en) | 2019-11-21 |
KR20200015897A (en) | 2020-02-13 |
EP3615029A2 (en) | 2020-03-04 |
KR20230167450A (en) | 2023-12-08 |
CA3061381A1 (en) | 2018-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201909967QA (en) | Formulations for extending lifespan and healthspan | |
SG11201901623TA (en) | Comb polymers for improving noack evaporation loss of engine oil formulations | |
SG11201909011PA (en) | Niraparib compositions | |
SG11201806758VA (en) | Vcn enhancer compositions and methods of using the same | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201808108XA (en) | Synthesis of indazoles | |
SG11201805056TA (en) | A variable behaviour control mechanism for a motive system | |
SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
SG11201903781QA (en) | Lubricant composition with an improved viscosity characteristic at low operating temperature | |
SG11201811230RA (en) | Compositions and methods for reducing ocular neovascularization | |
SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
SG11201810402PA (en) | Process for preparing high-reactivity isobutene homo- or copolymers | |
SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts | |
SG11201807523PA (en) | Ilt7 binding molecules and methods of using the same | |
SG11201805170XA (en) | Cellular glycosaminoglycan compositions and methods of making and using | |
SG11201811671XA (en) | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof | |
SG11201900486WA (en) | Treatment and prevention of sleep disorders | |
SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
SG11201808856TA (en) | Production of steviol glycosides in recombinant hosts | |
SG11201804587QA (en) | Isoindole compounds | |
SG11201408509PA (en) | Racecadotril lipid compositions | |
SG11201806424TA (en) | Therapeutic compounds |